Fidelity Investments’s Parabilis Medicines PBLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$337M Buy
10,867,584
+574,849
+6% +$20.1M 0.01% 691
2026
Q2
$282M Buy
+10,292,735
New +$284M 0.01% 786

Other funds holding PBLS

Fidelity Investments's PBLS Position: Q3 2026 in Review

Fidelity Investments increased its Parabilis Medicines (PBLS) stake by 5.6% in Q3 2026, buying an estimated $20.1M and bringing the position to 10,867,584 shares worth $337M. The position accounts for 0.01% of the portfolio, ranked #691.

Fidelity Investments first reported a position in PBLS in Q2 2026 and has held it in 2 quarters since. 127 funds tracked by Wall St. Rank hold PBLS as of Q3 2026.

  • Fidelity Investments held 10,867,584 shares of Parabilis Medicines worth $337M as of Q3 2026.
  • Fidelity Investments bought 574,849 Parabilis Medicines shares in Q3 2026, an estimated $20.1M.
  • Parabilis Medicines made up 0.01% of Fidelity Investments's portfolio in Q3 2026, its #691 holding.
  • Fidelity Investments first reported a position in Parabilis Medicines in Q2 2026 and has held it in 2 quarters since.
  • 127 funds tracked by Wall St. Rank held Parabilis Medicines as of Q3 2026.

Based on Fidelity Investments's 13F filing for Q3 2026, filed 10 Nov 2026.